Steinhoff International Holdings N.V.

  • WKN: A14XB9
  • ISIN: NL0011375019
  • Land: Niederlande

Nachricht vom 28.10.2021 | 17:11

Steinhoff International Holdings N.V. : ​​​​​​​LEAVE TO APPEAL GRANTED ON THE JURISDICTIONAL ISSUE

DGAP-News: Steinhoff International Holdings N.V. / Key word(s): Miscellaneous
28.10.2021 / 17:11
The issuer is solely responsible for the content of this announcement.

LEAVE TO APPEAL GRANTED ON THE JURISDICTIONAL ISSUE

Steinhoff International Holdings N.V. ("SIHNV" or the "Company" and together with its subsidiaries, "Steinhoff") provides the following update with respect to the liquidation application proceedings ("the liquidation application") launched by AJVH Holdings and four others ("the applicants") against the Company in the Cape Town High Court ("the Court").

As previously announced on 13 September 2021, following an initial hearing on 1 to 3 September 2021, on 6 September 2021, the Court granted an Order ("the 6 September Order") in terms of which the Court dismissed the application raised by the Company that the Court does not have jurisdiction to wind up SIHNV by virtue of the fact that SIHNV is an external foreign company ("the jurisdictional issue"). On 10 September 2021, the Court gave a further order, amongst other things, refusing postponement of the liquidation application ("the 10 September Order"). Reasons were given for the 6 September Order and the 10 September Order by the Court on 5 October 2021.

During hearings on 22, 26 and 27 October 2021, the Court has heard arguments from the Company, parties described as SIHNV Financial Creditors of SIHNV ("the financial creditors") and the applicants. The matters put before the court included:

1. applications from the Company and the financial creditors for leave to appeal on the jurisdictional issue following the 6 September Order;

2. an application from the financial creditors for leave to appeal the order refusing their application to intervene;

3. applications from the Company and the financial creditors for leave to appeal the 10 September Order; and

4. applications from the Company and the financial creditors to postpone the hearing of the liquidation application pending the outcome of the appeals set out above.

Today the Court issued its ruling granting the Company, and the financial creditors, leave to appeal to the Supreme Court of Appeal with respect to the jurisdictional issue, the financial creditors intervention application and the appeals against the 10 September Order, as well as granting the applications for postponement of the liquidation application pending the outcome of those appeals.

The Company has a primary listing on the Frankfurt Stock Exchange and a secondary listing on the JSE Limited.

Stellenbosch, South Africa
28 October 2021
 



28.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021